Adocia and Lilly initiate a Phase 1b study evaluating ultra-rapid BioChaperone Lispro in patients with type 1 diabetes using insulin pump therapy

Adocia Logo

Advancing Mealtime Insulin Therapy:
Phase 3 Results for BC Lispro in Type 2 Diabetes

Tuesday, June 16, 2026 | 10:00 AM ET / 4:00 PM CET

Click Here to Register & Attend